NERM
GEHC icon

New England Research & Management’s GE HealthCare GEHC Stock Holding History

New England Research & Management’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,661
Closed -$250K – 162
2024
Q3 		$250K Sell
2,661
-5,591
-68% -$469K 0.12% 144
2024
Q2 		$643K Buy
8,252
+2,814
+52% +$230K 0.31% 101
2024
Q1 		$494K Sell
5,438
-15,215
-74% -$1.27M 0.24% 116
2023
Q4 		$1.6M Sell
20,653
-5,808
-22% -$407K 0.85% 39
2023
Q3 		$1.8M Buy
+26,461
New +$1.93M 1.03% 29

Other funds holding GEHC

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

New England Research & Management's GEHC Position: Q4 2024 in Review

New England Research & Management sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 2,661 shares — an estimated $250K sold.

New England Research & Management first reported a position in GEHC in Q3 2023 and held it in 5 quarters. The position peaked at $1.8M in Q3 2023. 1,327 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

  • New England Research & Management reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
  • New England Research & Management sold 2,661 GE HealthCare shares in Q4 2024, an estimated $250K.
  • New England Research & Management first reported a position in GE HealthCare in Q3 2023 and held it in 5 quarters.
  • New England Research & Management's GE HealthCare position peaked at $1.8M in Q3 2023.
  • 1,327 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on New England Research & Management's 13F filing for Q4 2024, filed 23 Jan 2025.